Frontlight ResearchEarly access
Atopic dermatitis (eczema) trials in Poland
26 of 26 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in PolandA Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated with Dupilumab.
- Where
- Cracow, Lodz, Tarnów, Warsaw, Warszawa, Wroclaw
- Age
- 18 years and over
- People
- 50 worldwide
- Run by
- Aslan Pharmaceuticals Pte Ltd
See details and how to joinNCT05694884 · EU 2023-508329-28-00